The largest database of trusted experimental protocols

5 protocols using mucin type 3

1

Cultivation and Characterization of Akkermansia muciniphila

Check if the same lab product or an alternative is used in the 5 most similar protocols
Akkermansia muciniphila (ATCC BAA-835) was provided from the DSMZ institute (German Collection of Microorganisms and Cell Cultures GmbH). A. muciniphila strains were cultured in brain heart infusion (BHI) agar medium (Quelab, Canada) supplemented with 0.5% mucin-type III (Sigma-Aldrich, St. Louis, Missouri, USA), hemin (5 μg/ml), menadione (1 μg/ml)45 (link) and 0.05% L-cysteine46 (link) under anaerobic conditions (80% N2, 10% H2, and 10% CO2) at 37 °C for 3–7 days as described previously12 (link).
Polymerase chain reaction (PCR) test was performed based on 16 s ribosomal ribonucleic acid (rRNA) sequence recognition to confirm the A. muciniphila, in addition to macroscopic and microscopic (Gram staining) assays (Supplementary Table 1).
Cell-free supernatant was obtained from the inoculation of A. muciniphila in 100 mL BHI broth with the above-mentioned supplementations incubated in the same condition reaching optical density (OD) of 1.5 in 600 nm, centrifuged in 8000 × g for 5 min; the pH was adjusted in 7.4 and then purified by passing through 2.22 nm filters and kept at −70 °C until usage.
+ Open protocol
+ Expand
2

Fecal Slurry Model for Gut Microbiome Dynamics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell-free culture supernatants from the proximal and distal colon, both in resting conditions (basal) and after immune challenges (LPS and IL-15), were subsequently used to explore their effect on a stable fecal population via the fecal slurry model. For this purpose, we used a basal media composed of 2 g/l peptone water [Becton, Dickinson and Company (BD), Franklin Lakes, NJ, USA] 2 g/l yeast extract (BD), 0.1 g/l NaCl, 0.04 g/l K2HPO4, 0.04 g/l KH2PO4, 0.01 g/l MgSO4, 0.01 g/l CaCl2.⋅2H2O, 2 g/l NaHCO3, 2.5 g/l l-Cysteine-HCl, 0.5 g/l bile salts, 2 ml/l Tween-80, 1 g/l arabinogalactan, 2 g/l pectin, 1 g/l xylan, 4 g/l starch, 0.4 g/l glucose, and 0.4 g/l mucin type III (all purchased to Sigma-Aldrich). The mixture was homogenized and autoclaved for 15 min at 121°C, and the following components were added to the cooled media after sterilization by filtration (0.20 μm): 0.05 g/l bovine hemin (Sigma-Aldrich) and 10 μg/l vitamin K (Sigma-Aldrich). Before use, the basal media was maintained overnight at 37°C in anaerobiosis (10% v/v H2, 10%CO2, and 80% N2) in an anaerobic chamber Mac 500 (Don Whitley Scientific, West Yorkshire, UK).
+ Open protocol
+ Expand
3

Influenza Virus Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fetal bovine serum (FBS) was obtained from Biochrom AG (Berlin, Germany). Trypsin-EDTA, L-glutamine, penicillin G sodium, streptomicin sulfate, and amphotericin B were obtained from Invitrogen Corp. (NY, USA). Mucin type III, extracted from porcine stomach, was obtained from Sigma-Aldrich (MO, USA). Dulbecco's Modified Eagle's Medium (DMEM) and MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] were obtained from GIBCO (NY, USA). Trehalose was bought from Mana Chemical (Bangkok, Thailand). Branched polyethylenimine (PEI; molecular weight 25 kDa) was purchased from Sigma-Aldrich (MO, USA). Chitosan polymers having molecular weights (Mw) of 10 kDa and 22 kDa were purchased from OilZac Technologies Co., Ltd. (Bangkok, Thailand) while 600 kDa chitosan was purchased from Seafresh Chitosan (Lab) Co., Ltd. (Chumphon, Thailand). Degrees of deacetylation (DD) in chitosan polymers were determined to be between 94 and 98% by 1 H-NMR spectroscopy (27) . Anti-influenza A was obtained from Merck (Darmstadt, Germany) and goat anti-mouse IgG was from KPL (MD, USA).
+ Open protocol
+ Expand
4

HA Nanoparticle Synthesis and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hyaluronic acid sodium salt at 1% (w/v) was purchased from Mapric Pharmaceutical Products Ltd., (São Paulo, Brazil) (I-MM) and Euflexxa (São Paulo, Brazil) (H-MM). The HA from Mapric was used in the synthesis of HA nanoparticles. Water-soluble adipic acid dihydrazide (ADH), N, and N-dimethyl aminopropyl carbodiimide (EDC) were used for nanoparticle crosslinking and were purchased from Sigma (St. Louis, MO, USA). Ethanol and all other analytical grade chemicals were acquired from Merck (Darmstadt, Germany). Type III mucin (Sigma-Aldrich Ltd., São Paulo, Brazil) in partially purified powder from porcine stomach was used in the mucoadhesion assays.
+ Open protocol
+ Expand
5

Vinpocetine-loaded Polymer-based Nasal Formulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vinpocetine (VP, ethyl-apovincaminate) was applied as a model active substance purchased from Sigma-Aldrich Co., Ltd. (Budapest, Hungary). The Soluplus® (SP, poly(vinyl caprolactam)–poly(vinyl acetate)–poly(ethylene glycol) graft co-polymer (PCL-PVAc-PEG)) was kindly gifted from BASF GmbH (Hannover, Germany), and Poloxamer 188 (P 188, poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) (PEG-PPG-PEG)) was also acquired from Sigma-Aldrich Co., Ltd. D-trehalose dihydrate (D-TRE), chitosan (Chit, <100 kDa), sodium hyaluronate (Hya, low molecular weight, 20–40 kDa), hydroxypropyl methylcellulose (HPMC, average molecular weight: 10 kDa, viscosity of 80–120 cP, 2% in water (20 °C)); type III mucin and materials for the simulated nasal electrolyte solution (SNES) were also acquired from Sigma-Aldrich Co., Ltd. The composition of SNES was the following: 8.77 g/L of sodium chloride, 2.98 g/L of potassium chloride and 0.59 g/L of anhydrous calcium chloride in 1000 mL of purified water, adjusted to a pH of 5.6.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!